Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares
About this filing
Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Nov 10, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- SANJAY KESWANI
- Relationship
- Former Affiliate
- Shares to sell
- 53,614
- Market value
- $8,973,487.77
- Approximate sale date
- Nov 10, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired (1)
- Nov 10, 2026 · Exercise of Options Under a Registered Plan
- Acquired (2)
- Nov 10, 2026 · Exercise of Options Under a Registered Plan
- Acquired (3)
- Nov 10, 2026 · Exercise of Options Under a Registered Plan
- Acquired (4)
- Nov 10, 2026 · Exercise of Options Under a Registered Plan
More NBIX filings
- 4
Filed Nov 19, 2026
- 144
Filed Nov 17, 2026
- 4
Filed Nov 5, 2026
- 4
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 144
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.